Labaran Waya

Farko Kafaffen-Dose Haɗin Magungunan An ƙaddamar da shi don Nau'in Ciwon sukari na 2

Written by edita

Glenmark Pharmaceuticals Limited ta ƙaddamar da wani sabon ƙayyadaddun ƙayyadaddun adadin adadin (FDC) na mai hanawa DPP4 da aka fi amfani da shi (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, tare da Pioglitazone. Wannan ita ce kawai alamar haɗin haɗin DPP4 da Glitazone a Indiya don manya masu nau'in ciwon sukari na 2 marasa sarrafawa. Glenmark ya ƙaddamar da wannan FDC a ƙarƙashin sunan alamar Zita Plus Pio, wanda ya ƙunshi Teneligliptin (20 MG) + Pioglitazone (15 MG), wanda za a sha sau ɗaya a rana.

Da yake tsokaci game da ci gaba, Alok Malik, Mataimakin Shugaban Kungiyar & Shugaban, Tsarin Indiya - Glenmark Pharmaceuticals, ya ce, "Ciwon sukari shine babban yanki na mayar da hankali ga Glenmark; majagaba wajen ba da dama ga sabbin zaɓuɓɓukan magani ga masu ciwon sukari a Indiya. Muna farin cikin gabatar da wannan labari na Zita Plus Pio, wanda shine irinsa na farko a Indiya; tana ba da zaɓin jiyya mai daraja a duniya ga manya masu fama da ciwon sukari."

Glenmark shine kamfani na farko a Indiya don tallata sabon FDC na Teneligliptin + Pioglitazone, wanda DCGI (Mai Kula da Magunguna na Indiya) ya amince da shi. Wannan ƙayyadadden haɗe-haɗen kashi zai zama da amfani ga marasa lafiya waɗanda ke buƙatar magani tare da Teneliglitptin da Pioglitazone (a matsayin magunguna daban) don haɓaka sarrafa glycemic na rage juriya na insulin. 

Nau'in ciwon sukari na 2 yawanci suna fuskantar matsalolin rashin aikin sel da kuma juriya na insulin. Glenmark's FDC na Teneligliptin + Pioglitazone yana da inganci don magance waɗannan mahimman hanyoyin ilimin halittar jiki guda biyu waɗanda ke sa FDC ta fi tasiri a sarrafa nau'in ciwon sukari na 2 mara kulawa. Haɗin Teneligliptin + Pioglitazone zai samar da tsarin daidaitawa wanda Teneligliptin zai inganta ingantaccen ji na sel, kuma Pioglitazone zai rage juriya na insulin yadda ya kamata.

Gudunmawar Glenmark ga maganin ciwon sukari

WTM London 2022 Za a gudanar da shi daga 7-9 Nuwamba 2022. Yi rijista yanzu!

A cikin 2015, Glenmark ya canza kasuwar ciwon sukari ta hanyar ƙaddamar da mai hana DPP4 - Teneligliptin a Indiya, sannan FDC na Teneligliptin + Metformin ya biyo baya. Glenmark yana da ƙaƙƙarfan gado na fiye da shekaru arba'in na ci gaba da ƙima. A ci gaba zuwa karon farko a gadon Indiya, ta ƙaddamar da FDC na Teneligliptin + Remogliflozin a cikin 2021.

An san Indiya a matsayin helkwatar ciwon sukari a duniya. Bisa ga Ƙungiyar Ciwon sukari ta Duniya (IDF), yawan ciwon sukari a Indiya ya kai kimanin manya miliyan 74, wanda ake sa ran ya karu zuwa 125 miliyan (kusan karuwa 70%) ta 2045[i]. Daga cikin waɗannan, 77% na marasa lafiya suna da ciwon sukari marasa ƙarfi.

Shafin Farko

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...